TCRX vs. FIAC

Last updated Jun 4, 2026

TCRX (TScan Therapeutics, Inc.) and FIAC (Focus Impact Acquisition Corp.) are both stocks. TCRX operates in Biotechnology (Healthcare), while FIAC operates in Shell Companies (Financial Services). At a correlation of -0.00, they often move in opposite directions.

Performance

TCRX vs. FIAC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TScan Therapeutics, Inc. (TCRX) and Focus Impact Acquisition Corp. (FIAC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

TCRX

• 1D: -0.82%
• 1M: -20.33%
• YTD: -2.80%
• 6M: -4.71%
• 1Y: -44.46%
• 3Y*: -29.80%
• 5Y*: —
• 10Y*: —

FIAC

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TCRX vs. FIAC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
TCRX TScan Therapeutics, Inc.	-2.80%	-67.11%	-47.86%	276.13%	-65.56%	-7.41%
FIAC Focus Impact Acquisition Corp.	0.00%	0.00%	-81.54%	6.97%	3.14%	-0.30%

Correlation

The correlation between TCRX and FIAC is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	-0.00
Correlation (All Time) Calculated using the full available price history since Dec 27, 2021	-0.00

Fundamentals

Market Cap TCRX : $126.28M FIAC : $8.56M
EPS TCRX : -$0.96 FIAC : -$1.66
PS Ratio TCRX : 15.48 FIAC : 328.00
Total Revenue (TTM) TCRX : $8.15M FIAC : $18.31K
Gross Profit (TTM) TCRX : $6.66M FIAC : $6.96K
EBITDA (TTM) TCRX : -$129.32M FIAC : -$5.47M

Return for Risk

TCRX vs. FIAC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TCRX

TCRX Risk / Return Rank: 20
TCRX Sharpe Ratio Rank: 18
TCRX Sortino Ratio Rank: 23
TCRX Omega Ratio Rank: 23
TCRX Calmar Ratio Rank: 16
TCRX Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TCRX vs. FIAC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TScan Therapeutics, Inc. (TCRX) and Focus Impact Acquisition Corp. (FIAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TCRX	FIAC	Difference
Sharpe ratio Return per unit of total volatility	-0.52	—	—
Sortino ratio Return per unit of downside risk	-0.35	—	—
Omega ratio Gain probability vs. loss probability	0.96	—	—
Calmar ratio Return relative to maximum drawdown	-0.69	—	—
Martin ratio Return relative to average drawdown	-1.01	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	TCRX	FIAC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.52	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.39	—	—

Drawdowns

Drawdown Indicators

	TCRX	FIAC	Difference
Max Drawdown Largest peak-to-trough decline	-93.36%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-64.46%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-90.58%	—	—
Current Drawdown Current decline from peak	-92.79%	—	—
Average Drawdown Average peak-to-trough decline	-71.82%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	44.25%	—	—

Volatility

Volatility by Period

	TCRX	FIAC	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.58%	—	—
Volatility (6M) Calculated over the trailing 6-month period	50.67%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	87.56%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	98.20%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	98.20%	—	—

Dividends

TCRX vs. FIAC - Dividend Comparison

Neither TCRX nor FIAC has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both TCRX and FIAC in my portfolio?

TCRX and FIAC have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.